JPRN-jRCTs041230132招募中1 期
Exploratory study of imiquimod topical therapy for Bowen's disease
Yoshikawa Shusuke0 个研究点目标入组 12 人开始时间: 2024年2月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Histopathologically diagnosed Bowen's disease on biopsy
- •(2) Tumor lesion size of 10 mm or greater on the trunk and extremities, excluding lesions on the head and neck, fingernail area, external genitalia, and perianal area.
- •(3) Obvious neoplastic lesion on pre-registration CT.
- •(4) Over 18 years old
- •(5) Written consent to participate in the study has been obtained from the patient
- •(6) ECOG PS 0-2
排除标准
- •(1) Previous topical treatment, cryotherapy, radiation therapy, or post-surgical treatment for Bowen's disease
- •(2) Multiple Bowen lesions
- •(3) Strong inflammatory findings
- •(4) Systemic infection
- •(5) Difficulty in performing topical treatment as prescribed
- •(6) Psychiatric illness or psychiatric symptoms that interfere with daily life
- •(7) On continuous administration of steroids or other immunosuppressive drugs
- •(8) Patients with a history of hypersensitivity to imiquimod
- •(9) Patients who are judged to be inappropriate for this study by the treating physician.
研究者
相似试验
尚未招募
3 期
The effect of topical Imiquimod5% in treatment of high-grade cervical neoplasias (CIN2,3)The recovery rate of high-grade cervical neoplasias.IRCT20230811059116N1Iran University of Medical Sciences80
进行中（未招募）
1 期
Topical Imiquimod in Treating Patients with Grade 2/3 Cervical Intraepithelial Neoplasia - ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-TrialGrade 2/3 Cervical Intraepithelial NeoplasiaMedDRA version: 9.1Level: LLTClassification code 10049701Term: Cervical intraepithelial neoplasia IIMedDRA version: 9.1Level: LLTClassification code 10049702Term: Cervical intraepithelial neoplasia IIIEUCTR2008-007763-16-ATMedizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Gynäkologie und Gyn.Onkologie60
进行中（未招募）
1 期
Topical Imiquimod in Treating Patients with Persistent HPV-Infection after Surgical or Radiation Treatment of Cervical Cancer - TACTIQ (Treatment after Cervical Cancer with topical Imiquimod)-trialEUCTR2010-019657-18-ATMedizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Gynäkologie und Gyn.Onkologie
终止
3 期
Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial NeoplasiaCervical Intraepithelial NeoplasiaNCT01283763Medical University of Vienna95
已完成
早期 1 期
Neoadjuvant Imiquimod Immunotherapy for Oral CancerNCT04883645Medical University of South Carolina16